⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 26, 2024Photodiagnosis and Photodynamic TherapyOpen Access

Photodynamic therapy inhibits cancer progression and induces ferroptosis and apoptosis by targeting P53/GPX4/SLC7A11 signaling pathways in cholangiocarcinoma

Xiaodong Yan Zhongmin Li Huaiyu Chen Yang Fu Qing Tian Yamin Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Cholangiocarcinoma (CCA) is a malignant tumor with a poor prognosis. The specific mechanism of photodynamic therapy (PDT) in treating CCA remains unclear. This study aims to investigate the mechanisms of PDT in the treatment of CCA and try to improve the therapeutic effect of PDT by intervening associated signaling pathways.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yan et al. (2024) studied this question.

synapsesocial.com/papers/68e6d58fb6db643587652cf1 https://doi.org/10.1016/j.pdpdt.2024.104104

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of photodynamic therapy on peripheral immune system for unresectable cholangiocarcinoma2024 · 4 citations
2Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models2024 · 10 citations
3Targeting taurine metabolism via PROTAC-mediated SLC6A6 degradation potentiates photodynamic therapy and reverses immunosuppression in cholangiocarcinomaOriginal Research · 2026
4Endobiliary Photodynamic Therapy in Cholangiocarcinoma: Clinical Outcomes, Patient Selection, and Procedural ContextLiterature Review · 2026
5Overcoming Photodynamic Therapy Resistance: GSH‐Responsive AIE Photosensitizer‐Hydroxycamptothecin Nanoliposomes for Extrahepatic CholangiocarcinomaIn Vitro Study · 2026 · 1 citations